RB1 c.175_177delinsTGT ;(p.A59C)

Variant ID: 13-48881453-GCA-TGT

NM_000321.2(RB1):c.175_177delinsTGT;(p.A59C)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer.

Endocrine-Related Cancer
Wong, Kristen K; Di Cristofano, Francesca F; Ranieri, Michela M; De Martino, Daniela D; Di Cristofano, Antonio A
Publication Date: 2019-04-01

Variant appearance in text: RB1: A59C
PubMed Link: 30699064
Variant Present in the following documents:
  • Main text
View BVdb publication page